These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
382 related articles for article (PubMed ID: 28467784)
1. In silico gene expression analysis reveals glycolysis and acetate anaplerosis in IDH1 wild-type glioma and lactate and glutamate anaplerosis in IDH1-mutated glioma. Khurshed M; Molenaar RJ; Lenting K; Leenders WP; van Noorden CJF Oncotarget; 2017 Jul; 8(30):49165-49177. PubMed ID: 28467784 [TBL] [Abstract][Full Text] [Related]
2. Isocitrate dehydrogenase 1-mutated human gliomas depend on lactate and glutamate to alleviate metabolic stress. Lenting K; Khurshed M; Peeters TH; van den Heuvel CNAM; van Lith SAM; de Bitter T; Hendriks W; Span PN; Molenaar RJ; Botman D; Verrijp K; Heerschap A; Ter Laan M; Kusters B; van Ewijk A; Huynen MA; van Noorden CJF; Leenders WPJ FASEB J; 2019 Jan; 33(1):557-571. PubMed ID: 30001166 [TBL] [Abstract][Full Text] [Related]
3. Metabolic changes related to the IDH1 mutation in gliomas preserve TCA-cycle activity: An investigation at the protein level. Dekker LJM; Wu S; Jurriëns C; Mustafa DAN; Grevers F; Burgers PC; Sillevis Smitt PAE; Kros JM; Luider TM FASEB J; 2020 Mar; 34(3):3646-3657. PubMed ID: 31960518 [TBL] [Abstract][Full Text] [Related]
4. Nuclear FABP7 regulates cell proliferation of wild-type IDH1 glioma through caveolae formation. Kagawa Y; Umaru BA; Kanamori M; Zama R; Shil SK; Miyazaki H; Kobayashi S; Wannakul T; Yang S; Tominaga T; Owada Y Mol Oncol; 2022 Jan; 16(1):289-306. PubMed ID: 34716958 [TBL] [Abstract][Full Text] [Related]
5. Modeling the diffusion of D-2-hydroxyglutarate from IDH1 mutant gliomas in the central nervous system. Linninger A; Hartung GA; Liu BP; Mirkov S; Tangen K; Lukas RV; Unruh D; James CD; Sarkaria JN; Horbinski C Neuro Oncol; 2018 Aug; 20(9):1197-1206. PubMed ID: 29660019 [TBL] [Abstract][Full Text] [Related]
6. MR-detectable metabolic biomarkers of response to mutant IDH inhibition in low-grade glioma. Molloy AR; Najac C; Viswanath P; Lakhani A; Subramani E; Batsios G; Radoul M; Gillespie AM; Pieper RO; Ronen SM Theranostics; 2020; 10(19):8757-8770. PubMed ID: 32754276 [TBL] [Abstract][Full Text] [Related]
7. Glioma cells with the IDH1 mutation modulate metabolic fractional flux through pyruvate carboxylase. Izquierdo-Garcia JL; Cai LM; Chaumeil MM; Eriksson P; Robinson AE; Pieper RO; Phillips JJ; Ronen SM PLoS One; 2014; 9(9):e108289. PubMed ID: 25243911 [TBL] [Abstract][Full Text] [Related]
8. Adaptive Evolution of the GDH2 Allosteric Domain Promotes Gliomagenesis by Resolving IDH1 Waitkus MS; Pirozzi CJ; Moure CJ; Diplas BH; Hansen LJ; Carpenter AB; Yang R; Wang Z; Ingram BO; Karoly ED; Mohney RP; Spasojevic I; McLendon RE; Friedman HS; He Y; Bigner DD; Yan H Cancer Res; 2018 Jan; 78(1):36-50. PubMed ID: 29097607 [TBL] [Abstract][Full Text] [Related]
9. A glycolysis-based ten-gene signature correlates with the clinical outcome, molecular subtype and IDH1 mutation in glioblastoma. Chen C; Shi Y; Li Y; He ZC; Zhou K; Zhang XN; Yang KD; Wu JR; Kung HF; Ping YF; Bian XW J Genet Genomics; 2017 Nov; 44(11):519-530. PubMed ID: 29169920 [TBL] [Abstract][Full Text] [Related]
10. Integrated Metabolomics and Lipidomics Analyses Reveal Metabolic Reprogramming in Human Glioma with IDH1 Mutation. Zhou L; Wang Z; Hu C; Zhang C; Kovatcheva-Datchary P; Yu D; Liu S; Ren F; Wang X; Li Y; Hou X; Piao H; Lu X; Zhang Y; Xu G J Proteome Res; 2019 Mar; 18(3):960-969. PubMed ID: 30596429 [TBL] [Abstract][Full Text] [Related]
11. D-2-HG Inhibits IDH1mut Glioma Growth via FTO Inhibition and Resultant m6A Hypermethylation. Pianka ST; Li T; Prins TJ; Eldred BSC; Kevan BM; Liang H; Zapanta Rinonos S; Kornblum HI; Nathanson DA; Pellegrini M; Liau LM; Nghiemphu PL; Cloughesy TF; Lai A Cancer Res Commun; 2024 Mar; 4(3):876-894. PubMed ID: 38445960 [TBL] [Abstract][Full Text] [Related]
12. Diagnostic value of glutamate with 2-hydroxyglutarate in magnetic resonance spectroscopy for IDH1 mutant glioma. Nagashima H; Tanaka K; Sasayama T; Irino Y; Sato N; Takeuchi Y; Kyotani K; Mukasa A; Mizukawa K; Sakata J; Yamamoto Y; Hosoda K; Itoh T; Sasaki R; Kohmura E Neuro Oncol; 2016 Nov; 18(11):1559-1568. PubMed ID: 27154922 [TBL] [Abstract][Full Text] [Related]
13. Overexpression of isocitrate dehydrogenase-1R¹³²H enhances the proliferation of A172 glioma cells via aerobic glycolysis. Nie Q; Guo P; Guo L; Lan J; Lin Y; Guo F; Zhou S; Ge J; Mao Q; Li X; Qiu Y Mol Med Rep; 2015 May; 11(5):3715-21. PubMed ID: 25586175 [TBL] [Abstract][Full Text] [Related]
14. Hyperpolarized (13)C MR imaging detects no lactate production in mutant IDH1 gliomas: Implications for diagnosis and response monitoring. Chaumeil MM; Radoul M; Najac C; Eriksson P; Viswanath P; Blough MD; Chesnelong C; Luchman HA; Cairncross JG; Ronen SM Neuroimage Clin; 2016; 12():180-9. PubMed ID: 27437179 [TBL] [Abstract][Full Text] [Related]
15. Hyperpolarized [1-13C] glutamate: a metabolic imaging biomarker of IDH1 mutational status in glioma. Chaumeil MM; Larson PE; Woods SM; Cai L; Eriksson P; Robinson AE; Lupo JM; Vigneron DB; Nelson SJ; Pieper RO; Phillips JJ; Ronen SM Cancer Res; 2014 Aug; 74(16):4247-57. PubMed ID: 24876103 [TBL] [Abstract][Full Text] [Related]
16. Metabolomic comparison between cells over-expressing isocitrate dehydrogenase 1 and 2 mutants and the effects of an inhibitor on the metabolism. Wen H; Cho HR; Yun T; Kim H; Park CK; Lee SH; Choi SH; Park S J Neurochem; 2015 Jan; 132(2):183-93. PubMed ID: 25251602 [TBL] [Abstract][Full Text] [Related]
17. Glutamate Is a Noninvasive Metabolic Biomarker of IDH1-Mutant Glioma Response to Temozolomide Treatment. Subramani E; Radoul M; Najac C; Batsios G; Molloy AR; Hong D; Gillespie AM; Santos RD; Viswanath P; Costello JF; Pieper RO; Ronen SM Cancer Res; 2020 Nov; 80(22):5098-5108. PubMed ID: 32958546 [TBL] [Abstract][Full Text] [Related]
18. Increased RLIP76 expression in IDH1 wild‑type glioblastoma multiforme is associated with worse prognosis. Wang Q; Zhang L; Cui Y; Zhang C; Chen H; Gu J; Qian J; Luo C Oncol Rep; 2020 Jan; 43(1):188-200. PubMed ID: 31746408 [TBL] [Abstract][Full Text] [Related]
19. Metabolism of glioma and IDH1/IDH2 mutations. Rossetto M; Ciccarino P; Boisselier B; Labussiere M; Sanson M Rev Neurol (Paris); 2011 Oct; 167(10):699-703. PubMed ID: 21885076 [TBL] [Abstract][Full Text] [Related]
20. Metabolic reprogramming associated with aggressiveness occurs in the G-CIMP-high molecular subtypes of IDH1mut lower grade gliomas. Ruiz-Rodado V; Malta TM; Seki T; Lita A; Dowdy T; Celiku O; Cavazos-Saldana A; Li A; Liu Y; Han S; Zhang W; Song H; Davis D; Lee S; Trepel JB; Sabedot TS; Munasinghe J; Yang C; Herold-Mende C; Gilbert MR; Cherukuri MK; Noushmehr H; Larion M Neuro Oncol; 2020 Apr; 22(4):480-492. PubMed ID: 31665443 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]